Literature DB >> 28197467

Administration of antioxidants in chronic kidney disease.

Mohamad Reza Tamadon1, Mehrdad Zahmatkesh2, Seyed Seifollah Beladi Mousavi3.   

Abstract

Entities:  

Keywords:  Antioxidants; Chronic kidney disease; Hemodialysis

Year:  2015        PMID: 28197467      PMCID: PMC5297480     

Source DB:  PubMed          Journal:  J Nephropharmacol        ISSN: 2345-4202


× No keyword cloud information.

Implication for health policy/practice/research/medical education:

Majority of studies indicated that, antioxidants are helpful in hemodialysis patients, reducing the risk of cardiovascular events and increasing the quality of dialysis. Chronic kidney disease has been a health problem in the past, however, today has become a global health threat. The number of chronic renal failure patients is increasing and more than one million people in the end-stage of chronic renal failure are dying annually (1). These patients experience various problems and creating a change in their life is very useful. Fatigue is a common problem in dialysis patients. Fatigue is the most important complication of vitamin C deficiency. Vitamin C is a well-known antioxidant (2). Hemodialysis process decreased the necessary antioxidants and chronic renal failure associated with stress oxidative (3). Excessive production of free radicals is a state that called stress oxidative which is one of the reasons for vascular lesions (4). Free radicals affect on carbohydrates, protein, fat and DNA (5,6). Free radicals cause lipid peroxidation and degradation of molecules and cellular structures (endothelial cells and red blood cells) (7). Some studies have indicated to the increasing of free radicals caused by dialysis (8-10). Small proteins such as immunoglobulin G and complements attached to the dialyzer membrane and activate granulocytes which resulting in production of free radicals (11,12). One of the main causes of death in chronic dialysis patients is cardiovascular events. Increasing of peroxidation products and also antioxidant depletion are effective actors of atherosclerosis in patients who undergoing hemodialysis (13). Chronic kidney disease associated with high incidence of cardiovascular disease which is common cause of mortality and also imposes high costs (5,6). Chronic renal insufficiency even if you eliminate the initial cause progress to end-stage renal disease, because the initial injury eventually leads to scarring and loss of renal nephrons and resulting in end-stage kidney disease (7-14). Various investigations mentioned the positive effects of antioxidants in chronic diseases, cardiovascular diseases, hypertension and kidney disease, although some studies have been reported no beneficial effect on reducing mortality and cardiovascular disease (15-21). Antioxidants are in foods and some studies mentioned to their beneficial role in chronic kidney disease or hypertension (22,23). This article, reviews some articles regarding the role of antioxidants in hemodialysis patients. We searched scientific sources and article index databases including PubMed and Scopus by key words including antioxidants, antioxidant therapy in hemodialysis patients, hemodialysis and antioxidants. From the existing articles we reviewed 48 articles. In study by Santana-Santos et al. (24), administration of N-acetylcysteine was effective in reducing of acute kidney injury in patients with kidney disease who underwent CABG surgery and mentioned that prevented from oxidative stress. However, other study implied that it had not any effect in acute renal injury and chronic kidney disease (25). Tbahriti et al. (26), in their study detected the antioxidant enzyme activities change under the influence of renal dysfunction and dialysis. In another study prescription of an antioxidant, alpha lipoic acid has been useful for diabetic and dialysis patients, while, the most common cause of reaching to the end-stage renal disease in the most communities is diabetes (27). However, various studies have been reported conflicting results. In a study, antioxidants have been effective in patients with non-dialysis kidney diseases but were not effective in dialysis patients (28-30). Additionally, the impact of anti-oxidants to reduce mortality resulting from cardiovascular diseases has been of much interest (31-33). Some studies reported that cytokines level is higher in hemodialysis patients and have important pathological role in oxidative stress, progression of diabetes complications and increasing the oxidative stress intensity after hemodialysis and emphased to antioxidants benefits in diabetic and end-stage renal disease patients who are under dialysis (34-36). It is possible that, reducing the activity of antioxidant enzyme in red blood cells and increasing of lipid peroxidation in hemodialysis patients play a role in progression of cardiovascular disease and antioxidants are effective to reduce cardiovascular events (37-39). Moreover, some studies point out that the use of dialyzer with antioxidant membrane, taking vitamin D and iron supplements and prescribed antioxidants such as vitamin E and C increase the quality of dialysis and reduce the incidence of oxidative stress and some complications (40-45). Likewise, the effect of low doses of vitamin C on the inflammatory process and reducing of fatigue in hemodialysis patients was emphasized in recent studies (46-48). According to these findings more studies are necessary to exactly find the effects of antioxidants in hemodialysis patients and reducing complications from dialysis and kidney disease. We recommend to assess their effects and determining a comprehensive therapeutic protocol for antioxidants therapy in hemodialysis patients.

Conclusion

Majority of studies indicated that, antioxidants are helpful in hemodialysis patients, reducing the risk of cardiovascular events and increasing the quality of dialysis.

Authors’ contributions

All authors contributed to the manuscript equally.

Conflict of interests

The authors declared no competing interests.

Ethical considerations

Ethical issues (including plagiarism, misconduct, data fabrication, falsification, double publication or submission, redundancy) have been completely observed by the authors.

Funding/Support

None.
  40 in total

1.  The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis.

Authors:  Fereshteh Saddadi; Sudabeh Alatab; Farahnaz Pasha; Mohammad Reza Ganji; Tayebeh Soleimanian
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-01

2.  Increased lipid peroxidation in patients on maintenance hemodialysis.

Authors:  A Dasgupta; S Hussain; S Ahmad
Journal:  Nephron       Date:  1992       Impact factor: 2.847

3.  Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-α in patient with ESRD undergoing hemodialysis.

Authors:  Javid Safa; Mohammad Reza Ardalan; Mohammadamin Rezazadehsaatlou; Mehran Mesgari; Reza Mahdavi; Maryam Poorkar Jadid
Journal:  Int Urol Nephrol       Date:  2014-04-13       Impact factor: 2.370

Review 4.  Radical approach to diabetic nephropathy.

Authors:  H B Lee; J Y Seo; M R Yu; S-T Uh; H Ha
Journal:  Kidney Int Suppl       Date:  2007-08       Impact factor: 10.545

5.  Assessment of DNA oxidation and antioxidant activity in hypertensive patients with chronic kidney disease.

Authors:  Yildiz Dincer; Nigar Sekercioglu; Meltem Pekpak; Kezban N Gunes; Tulay Akcay
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

Review 6.  Mitochondrial dysfunction in the pathophysiology of renal diseases.

Authors:  Ruochen Che; Yanggang Yuan; Songming Huang; Aihua Zhang
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-04

7.  Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

Authors:  Jonathan Himmelfarb; T Alp Ikizler; Charles Ellis; Pingsheng Wu; Ayumi Shintani; Sanjay Dalal; Mark Kaplan; Michel Chonchol; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 10.121

8.  Oxidative stress in Egyptian hemodialysis children.

Authors:  Emad E Ghobrial; Nermine N Mahfouz; Gihan A Fathy; Amany A Elwakkad; Heba M R Sebaii
Journal:  Iran J Kidney Dis       Date:  2013-11       Impact factor: 0.892

9.  Lipid peroxidation as an indicator of biocompatibility in haemodialysis.

Authors:  T Sanaka; C Higuchi; T Shinobe; H Nishimura; M Omata; H Nihei; N Sugino
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

10.  Antioxidants in kidney diseases: the impact of bardoxolone methyl.

Authors:  Jorge Rojas-Rivera; Alberto Ortiz; Jesus Egido
Journal:  Int J Nephrol       Date:  2012-06-04
View more
  5 in total

1.  Ameliorative effects of histidine on oxidative stress, tumor necrosis factor alpha (TNF-α), and renal histological alterations in streptozotocin/nicotinamide-induced type 2 diabetic rats.

Authors:  Maryam Nasri; Sina Mahdavifard; Esmaeel Babaeenezhad; Glavizh Adibhesami; Negar Nouryazdan; Saeid Veiskarami; Sobhan Rahimi Monfared; Mehdi Birjandi; Hassan Ahmadvand
Journal:  Iran J Basic Med Sci       Date:  2020-06       Impact factor: 2.699

Review 2.  Antioxidant plants and diabetes mellitus.

Authors:  Hamid Nasri; Hedayatollah Shirzad; Azar Baradaran; Mahmoud Rafieian-Kopaei
Journal:  J Res Med Sci       Date:  2015-05       Impact factor: 1.852

3.  Polyphenolic compounds of amla prevent oxidative stress and fibrosis in the kidney and heart of 2K1C rats.

Authors:  Md Mizanur Rahman; Khandoker Usran Ferdous; Shraboni Roy; Iffat Ara Nitul; Fariha Mamun; Md Hemayet Hossain; Nusrat Subhan; Md Ashraful Alam; Md Areeful Haque
Journal:  Food Sci Nutr       Date:  2020-05-20       Impact factor: 2.863

Review 4.  Role of Toxic Elements in Chronic Kidney Disease.

Authors:  Adwalia Fevrier-Paul; Adedamola K Soyibo; Sylvia Mitchell; Mitko Voutchkov
Journal:  J Health Pollut       Date:  2018-12-06

Review 5.  Soy Protein and Chronic Kidney Disease: An Updated Review.

Authors:  Mahmoud Rafieian-Kopaei; Sara Beigrezaei; Hamid Nasri; Marzieh Kafeshani
Journal:  Int J Prev Med       Date:  2017-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.